GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.900
+0.610 (14.22%)
Nov 22, 2024, 4:00 PM EST - Market closed
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 16 analysts with 12-month price forecasts for GoodRx Holdings stock have an average target of 9.03, with a low estimate of 6.00 and a high estimate of 16. The average target predicts an increase of 84.29% from the current stock price of 4.90.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GDRX stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 2 | 2 | 2 | 2 |
| Buy | 8 | 8 | 9 | 9 | 9 | 9 |
| Hold | 9 | 9 | 6 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 21 | 21 | 17 | 17 | 17 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Maintains $10 → $7 | Strong Buy | Maintains | $10 → $7 | +42.86% | Nov 13, 2024 |
| Barclays | Barclays | Buy Maintains $10 → $6 | Buy | Maintains | $10 → $6 | +22.45% | Nov 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $10 | Buy | Reiterates | $10 | +104.08% | Aug 16, 2024 |
| UBS | UBS | Hold Maintains $9 → $8.5 | Hold | Maintains | $9 → $8.5 | +73.47% | Aug 9, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $11 → $10 | Strong Buy | Maintains | $11 → $10 | +104.08% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
814.04M
from 750.27M
Increased by 8.50%
Revenue Next Year
878.76M
from 814.04M
Increased by 7.95%
EPS This Year
0.35
from -0.02
EPS Next Year
0.44
from 0.35
Increased by 23.14%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 842.1M | 936.8M | 1.1B | ||
| Avg | 814.0M | 878.8M | 983.0M | ||
| Low | 777.2M | 805.4M | 854.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.2% | 15.1% | 24.5% | ||
| Avg | 8.5% | 8.0% | 11.9% | ||
| Low | 3.6% | -1.1% | -2.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.42 | 0.54 | 0.69 | ||
| Avg | 0.35 | 0.44 | 0.56 | ||
| Low | 0.31 | 0.34 | 0.48 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 51.1% | 58.8% | ||
| Avg | - | 23.1% | 28.7% | ||
| Low | - | -3.2% | 10.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.